Información de la revista
Lo más citado
24
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysisMark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, ... Mazen Noureddin
Ann Hepatol. 2023;28:100762
24
Open access
![](https://static.elsevier.es/multimedia/16652681/0000002800000001/v2_202303281200/S1665268122001041/v2_202303281200/en/main.assets/ga1.jpeg)
16
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter studyKe Su, Qiuni Shen, Jian Tong, Tao Gu, Ke Xu, Han Li, Hao Chi, Yanlin Liu, ... Yunwei Han
Ann Hepatol. 2023;28:101109
16
Acceso a texto completo
16
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysisDaniela Contreras, Alejandra González-Rocha, Patricia Clark, Simón Barquera, Edgar Denova-Gutiérrez
Ann Hepatol. 2023;28:100873
16
Open access
![](https://static.elsevier.es/multimedia/16652681/0000002800000001/v2_202303281200/S1665268122002150/v2_202303281200/en/main.assets/ga1.jpeg)
13
Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research networkMarina Farah, Chimaobi Anugwom, Javier Diaz Ferrer, Estefania Liza Baca, Angelo Z. Mattos, João Pedro P. Possebon, Marco Arrese, Jhon Prieto, ... Jose D. Debes
Ann Hepatol. 2023;28:100876
13
Acceso a texto completo
12
Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver diseaseDongna Zhao, Haozhe Cui, Zhiqiang Shao, Liying Cao
Ann Hepatol. 2023;28:100726
12
Acceso a texto completo
11
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized studySamantha Thifani Alrutz Barcelos, Amanda Souza Silva-Sperb, Helena Abadie Moraes, Larisse Longo, Bruna Concheski de Moura, Matheus Truccolo Michalczuk, Carolina Uribe-Cruz, Carlos Thadeu Schmidt Cerski, ... Mário Reis Álvares-da-Silva
Ann Hepatol. 2023;28:100769
11
Open access
10
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of actionAlexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
10
Acceso a texto completo
8
Body mass index implications in intrahepatic cholestasis of pregnancy and placental histopathological alterationsVioleta Valdovinos-Bello, Carmen Selene García-Romero, Alicia Cervantes-Peredo, Elizabeth García-Gómez, Alejandra Martínez-Ibarra, Edgar Ricardo Vázquez-Martínez, Yolotzin Valdespino, Marco Cerbón
Ann Hepatol. 2023;28:100879
8
Open access
7
Metabolic dysfunction: The silenced connection with fatty liver diseaseMariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez
Ann Hepatol. 2023;28:101138
7
Acceso a texto completo
6
Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: from diagnosis to prognosisJiaxu Liang, Javier Ampuero, Javier Castell, Qiong Zhang, Sijia Zhang, Yong Chen, Manuel Romero-Gómez
Ann Hepatol. 2023;28:100889
6
Acceso a texto completo